BRCA2 and central nervous system neoplasm: Consistent with the occurrence of brain tumors in FANCD1-mutated patients [253], mice deficient for both Brca2 and p53 developed medulloblastoma, highlighting the importance of BRCA2 to neural development and CNS tumor suppression [254].